Nuvalent, Inc.
NUVL
31 insider filings · Latest: Jun 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Jan 6 1:54 AM | Alexandra Balcom | Proposed Sale | 7,417 | $97.58 | $723.8K | — | View → |
| Jan 6, 2026 | Jan 6 1:53 AM | James Richard Porter | Proposed Sale | 27,433 | $97.53 | $2.7M | — | View → |
| Dec 30, 2025 | Dec 30 9:03 PM | Darlene Noci | Proposed Sale | 15,000 | $101.60 | $1.5M | — | View → |
| Dec 8, 2025 | Dec 9 1:36 AM | Alexandra Balcom | Proposed Sale | 7,084 | $109.60 | $776.4K | — | View → |
| Nov 17, 2025 | Nov 17 9:37 PM | DEBORAH MILLER | Proposed Sale | 17,200 | $96.50 | $1.7M | — | View → |
| Nov 17, 2025 | Nov 17 9:09 PM | Alexandra Balcom | Proposed Sale | 13,854 | $93.72 | $1.3M | — | View → |
| Oct 30, 2025 | Oct 30 8:16 PM | DEBORAH MILLER | Proposed Sale | 22,800 | $102.97 | $2.3M | — | View → |
| Oct 27, 2025 | Oct 27 8:09 PM | Matthew Shair | Proposed Sale | 64,350 | $100.00 | $6.4M | — | View → |
| Oct 27, 2025 | Oct 27 8:06 PM | Matthew Shair | Proposed Sale | 18,150 | $100.00 | $1.8M | — | View → |
| Oct 16, 2025 | Oct 16 8:02 PM | James Richard Porter | Proposed Sale | 27,000 | $90.01 | $2.4M | — | View → |
| Oct 15, 2025 | Oct 15 8:37 PM | DEBORAH MILLER | Proposed Sale | 54,000 | $84.66 | $4.6M | — | View → |
| Oct 13, 2025 | Oct 14 8:08 PM | Alexandra Balcom | Proposed Sale | 48,558 | $89.32 | $4.3M | — | View → |
| Oct 13, 2025 | Oct 14 11:43 AM | HENRY E PELISH | Proposed Sale | 21,842 | $88.10 | $1.9M | — | View → |
| Sep 29, 2025 | Sep 29 8:08 PM | Darlene Noci | Proposed Sale | 12,000 | $81.30 | $975.6K | — | View → |
| Sep 29, 2025 | Sep 29 8:07 PM | Alexandra Balcom | Proposed Sale | 60,000 | $81.30 | $4.9M | — | View → |
| Sep 10, 2025 | Sep 10 8:38 PM | HENRY E PELISH | Proposed Sale | 6,158 | $78.73 | $484.8K | — | View → |
| Jul 24, 2025 | Jul 25 12:42 AM | BCLS II INVESTCO, LP | Proposed Sale | 4,253 | $82.08 | $349.1K | — | View → |
| Jul 24, 2025 | Jul 25 12:35 AM | BCIP Life Sciences Associates, LP | Proposed Sale | 156,670 | $82.08 | $12.9M | — | View → |
| Jul 24, 2025 | Jul 25 12:31 AM | Bain Capital Life Sciences Fund II, L.P. | Proposed Sale | 1,286,344 | $82.08 | $105.6M | — | View → |
| Jul 15, 2025 | Jul 15 8:01 PM | James Richard Porter | Proposed Sale | 81,000 | $84.59 | $6.9M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Jul 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 81,329(D) | View → |
| Jun 9, 2026 | Jun 11 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 20,000 | $18.93 | 24,258(D) | View → |
| Jun 8, 2026 | Jun 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 148,686(D) | View → |
| Jun 1, 2026 | Jun 3 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 13,400(D) | View → |
| May 28, 2026 | Jun 1 8:31 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 86,829(D) | View → |
| May 28, 2026 | Jun 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 72,608(D) | View → |
| May 4, 2026 | May 6 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $18.93 | 178,686(D) | View → |
| May 1, 2026 | May 5 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $6.89 | 24,830(D) | View → |
| Apr 30, 2026 | May 1 8:30 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 78,108(D) | View → |
| Apr 29, 2026 | May 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 92,329(D) | View → |
| Apr 9, 2026 | Apr 13 8:30 PM | Henry E. PelishChief Scientific Officer | Option Exercise | 3,093 | $27.85 | 8,309(D) | View → |
| Apr 6, 2026 | Apr 8 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $27.85 | 131,494(D) | View → |
| Apr 1, 2026 | Apr 3 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $1.08 | 138,796(D) | View → |
| Apr 1, 2026 | Apr 2 8:30 PM | Benjamin LaneChief Technical Operations Officer | Grant/Award | 19,000 | $105.64 | 19,000(D) | View → |
| Mar 30, 2026 | Apr 1 8:30 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 97,829(D) | View → |
| Mar 26, 2026 | Mar 30 9:31 PM | Deborah Ann MillerChief Legal Officer | Option Exercise | 5,500 | $6.89 | 83,608(D) | View → |
| Mar 24, 2026 | Mar 26 8:30 PM | Alexandra BalcomChief Financial Officer | Option Exercise | 11,430 | $1.08 | 150,226(D) | View → |
| Mar 12, 2026 | Mar 16 8:31 PM | Henry E. PelishChief Scientific Officer | Option Exercise | 17,320 | $72.35 | 21,073(D) | View → |
| Mar 6, 2026 | Mar 10 8:30 PM | James Richard PorterDirector, President and CEO | Option Exercise | 30,000 | $27.85 | 147,780(D) | View → |
| Feb 26, 2026 | Mar 2 9:34 PM | Darlene NociChief Development Officer | Option Exercise | 5,500 | $27.85 | 103,329(D) | View → |
Page 1 of 2
Next →